A detailed history of Farther Finance Advisors, LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 91 shares of CDMO stock, worth $1,104. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91
Previous 451 79.82%
Holding current value
$1,104
Previous $3.21 Million 67.74%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$6.7 - $12.45 $2,412 - $4,482
-360 Reduced 79.82%
91 $1.04 Million
Q2 2024

Jul 31, 2024

BUY
$6.34 - $9.28 $2,371 - $3,470
374 Added 485.71%
451 $3.21 Million
Q1 2024

May 13, 2024

BUY
$5.86 - $8.79 $363 - $544
62 Added 413.33%
77 $494,000
Q4 2023

Feb 14, 2024

BUY
$4.64 - $9.56 $259 - $535
56 New
56 $364,000
Q2 2023

May 13, 2024

SELL
$12.96 - $20.93 $531 - $858
-41 Reduced 73.21%
15 $210,000
Q2 2023

Sep 12, 2023

BUY
$12.96 - $20.93 $194 - $313
15 New
15 $210,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $755M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.